Semi-metallic SrIrO3 films using solid-source metal-organic molecular beam epitaxy

Autor: Rashmi Choudhary, Sreejith Nair, Zhifei Yang, Dooyong Lee, Bharat Jalan

Publikováno v: APL Materials, Vol 10, Iss 9, Pp 091118-091118-6 (2022)

Perovskite SrIrO3 films and its heterostructures are very promising, yet less researched, avenues to explore interesting physics originating from the interplay between strong spin–orbit coupling and electron correlations. Elemental iridium is a com

Externí odkaz: https://doaj.org/article/954f13d7bc31429d94ef83e8aa0d81ff

A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear)

Autor: Hussain Allawati, Linda Dallas, Sreejith Nair, Janine Palmer, Shaiju Thaikandy, Colin Hutchison

Publikováno v: Toxins, Vol 12, Iss 5, p 317 (2020)

Medium cut-off membrane (MCO) dialysers have been shown to remove a range of middle molecules, which are associated with adverse outcomes in haemodialysis (HD) patients, more effectively than high-flux HD. Vancomycin is widely used in HD patients for

Externí odkaz: https://doaj.org/article/e8c860a4329d482481df67ee8161d939

Reduced SrTiO3-supported Pt–Cu alloy nanoparticles for preferential oxidation of CO in excess hydrogen

Autor: Noopur Jain, Ahin Roy, Sreejith Nair

Publikováno v: Nanoscale. 11:22423-22431

Activity and long-term stability of oxide–metal heterostructure catalysts can be engineered through tuning the oxygen storage capacity (OSC) of the support and careful control of the composition of the supported metal nanoparticle. In this work, we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6eec9d3a3306144888fc5ac680e78092
https://doi.org/10.1039/c9nr07664f

Wideband Electrically Small Monopole antenna

Autor: M. G. Manoj, M Remsha, V A Shameena, M Sreejith Nair, P V Anila, Pezholil Mohanan

Publikováno v: 2020 XXXIIIrd General Assembly and Scientific Symposium of the International Union of Radio Science.

An electrically small monopole antenna operating in the WLAN frequency band is proposed in this paper. The antenna operates in 3.45-5.45 GHz WLAN frequency bands. Compact size, simple design and low cost make the antenna an attractive candidate for f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ece0278ef7713fe38681444c7f18b00
https://doi.org/10.23919/ursigass49373.2020.9232408

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Autor: Bernardo Garichochea, Judit Demeter, Yuankai Shi, Umberto Vitolo, Enrica Morra, Margarida Marques, Miklos Egyed, Toshiki Uchida, Árpád Illés, Kenichi Ishizawa, Cristina Ligia Cebotaru, Ashis Mukhopadhyay, Masafumi Taniwaki, Sung-Soo Yoon, Cristina-Ligia Truica, Cheol Won Suh, Irina Lysenko, Naokuni Uike, Huaqing Wang, Achiel Van Hoof, Maryna Kyselyova, Osmanov Ea, Andrew Belch, Alexy Kuzmin, Caballero Gabarrón, Steven Van Steenweghen, Sergio Cancelado, Olga Samoilova, Kensei Tobinai, Kiyoshi Ando, Susumu Nakahara, Tatiana Scheider, Massimo Federico, Dmitry Udovitsa, Xiaoyan Ke, Yurii Lorie, Tatsu Shimoyama, Weerasak Nawarawong, Sebastian Grosicki, Gregor Verhoef, Nuriet Khuageva, Suporn Chuncharune, Fritz Offner, Albert Oriol Rocafiguera, Charles Farber, Ernst Späth-Schwalbe, Juliana Pereira, Ting Liu, Lee-Yung Shih, Steven Le Gouill, Miklos Udvardy, Richard Greil, Carmen Cao, Tomohiro Kinoshita, Horia Bumbea, Yasuhito Terui, Eva Gonzalez-Barca, Irina Bulavina, Peter Hu, Francisco Javier Capote, Olga Serduk, Akihiro Tomita, Ilseung Choi, Mahmut Gumus, Udomsak Bunworasate, Adriana Teixeira, Vladimir Merkulov, Yeow Tee Goh, Tadeusz Robak, Huiqiang Huang, Jie Jin, Cristina Ileana Burcoveanu, Halyna Pylypenko, Joaquín Díaz, Herlander Marques, Zoltán Gasztonyi, Vijay Rao Phooshkooru, Gayane Tumyan, Maike De Wit, Ali Khojasteh, Marcelo Capra, Vladimir Lima, Dai Maruyama, Viacheslav Pavlov, Georg Heß, Carmino Antonio De Souza, Zhao Wang, Iryna Kryachok, Amel Mezlini, Galvez Cardenas, Marina Golubeva, Lyudmila Kuzina, Patricia Santi, Remy Gressin, Balkis Meddeb, Xiaonan Hong, David Belada, Bernard De Prijck, Jan Maciej Zaucha, Jiri Mayer, Michinori Ogura, Rumiko Okamoto, Dolores, Irit Avivi, Mario Ojeda-Uribe, Grigoriy B Rekhtman, Jun Zhu, Reyes Arranz, Polina Kaplan, André Bosly, Ann Van De Velde, Kenny Mauricio, Yuri Dunaev, Anatoly Golenkov, Oleg Gladkov, Yoshiharu Maeda, Franco Cavalli, Dina Ben Yehuda, Michele Baccarani, Markus Raderer, Razvan Stoia, Carlos Appiani, Zvenyslava Masliak, Zita Borbenyi, Guiseppe Rossi, Julia Alexeeva, Johannes Drach, Kateryna Vilchevskaya, Georgii Manikhas, Jan Novák, Noppadol Siritanaratkul, Zhixiang Shen, Alexander Suvorov, Michael Crump, Pierre Zachee, Ofer Shpilberg, Sepideh Nemat, Mitsutoshi Kurosawa, Sreejith Nair, Bulent Undar, Govind Babu, Kudrat Abdulkadryrov, Adriana Sheliga

Publikováno v: The Lancet Oncology. 19:1449-1458

Summary Background In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) were c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43dd418b74f44f31f1f62f0d52fde6f
https://doi.org/10.1016/s1470-2045(18)30685-5